结缔组织病患者开放胸腹主动脉修复的长期结局
该单中心回顾性研究纳入56例临床或基因诊断的结缔组织病(CTD)患者,均接受I-V型开放胸腹主动脉修复。30天死亡率为2%,1年死亡率为5%,随访期间内脏和肾动脉分支移植物通畅率良好,但肋间补片动脉瘤发生率达15%,需持续监测。
要点
- CTD患者开放胸腹主动脉修复的30天死亡率为2%,1年死亡率为5%。
- 随访期间腹腔干、肠系膜上动脉、左肾动脉和右肾动脉的一期通畅率分别为98%、100%、100%和94%。
- 肋间补片动脉瘤发生率为15%,其中5例需腔内修复,强调持续监测的必要性。
核心结论
- CTD患者行开放胸腹主动脉修复安全可行,短期和长期结局良好,内脏和肾动脉分支移植物通畅持久。
- 术后需持续监测移植物相关并发症,尤其是肋间补片动脉瘤,部分需干预。
研究设计与样本
- 回顾性单中心研究,纳入2013至2025年间接受I-V型开放胸腹主动脉修复的临床或基因诊断CTD患者56例。
- 平均年龄42±12岁,68%(n=38)为男性;68%(n=38)诊断为Marfan综合征,14%(n=8)为Loeys-Dietz综合征。
主要发现
- 30天死亡率为2%(n=1),1例死于术中体外循环脱机失败;1年死亡率为5%(n=3)。
- 延长机械通气>48小时4例(7%),其中2例(4%)需气管切开;内脏缺血4例(7%)。
- 脊髓缺血伴短暂轻瘫1例(2%),出院时需透析的肾衰竭2例(4%)。
- 平均影像随访59±48个月,腹腔干、肠系膜上动脉、左肾动脉和右肾动脉一期通畅率分别为98%、100%、100%和94%。
- 移植物相关并发症主要为肋间补片动脉瘤,发生8例(15%),其中5例需腔内修复;平均随访68±47个月,生存率89%。
临床怎么用
- 对于CTD合并胸腹主动脉病变患者,开放修复可作为安全选择,围术期死亡率低。
- 术后应长期影像监测,重点关注肋间补片动脉瘤等移植物相关并发症,必要时行腔内干预。
局限性
- 回顾性单中心设计,样本量有限(56例),可能存在选择偏倚。
- 随访时间不均一,部分患者随访时间较短。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aims to evaluate the short- and long-term outcomes of open thoracoabdominal aortic repair in patients with connective tissue disease (CTD). METHODS: Retrospective single-institutional review of patients with clinically or genetically diagnosed CTD who underwent extent I-V open thoracoabdominal aortic repair between 2013 and 2025. The primary outcomes were 30-day and 1-year mortality. Secondary outcomes included neurologic, renal, cardiac, and pulmonary complications, visceral ischemia, long-term branch-graft patency, graft-related complications, and survival. RESULTS: During the study period, 146 patients underwent open thoracoabdominal aortic repair, 56 patients with CTD were included in the analysis. Average age was 42 ± 12 years, and 68% patients (n = 38) were male. Most of the patients were diagnosed with Marfan syndrome (68%, n = 38), followed by Loeys-Dietz syndrome (14%, n = 8). Ninety-one percent of repairs were done electively for postdissection aneurysms (n = 51) requiring extent II thoracoabdominal aortic repair (68%, n = 38). Visceral and/or renal artery reconstructions were performed in nearly all patients (96%, n = 54). Most patients had previous aortic surgery performed (89%, n = 50). The 30-day mortality was 2% (n = 1), with one patient dying intraoperatively secondary to failure to wean from cardiopulmonary bypass. The 1-year mortality was 5% (n = 3). Prolonged ventilator support >48 hours occurred in four patients (7%), with two (4%) requiring tracheostomy placement. Visceral ischemia occurred in four patients (7%). One patient (2%) had spinal cord ischemia with transient paraparesis, and two (4%) had renal failure requiring dialysis at discharge. At a mean imaging follow-up time of 59 ± 48 months, the primary patency of the celiac, superior mesenteric, left renal and right renal arteries were 98%, 100%, 100%, and 94%, respectively. Graft-related complications were mainly secondary to intercostal patch aneurysms, which occurred in eight patients (15%), five of whom necessitated endovascular repair. At a mean follow-up of 68 ± 47 months, the survival of operated cohort was 89%. CONCLUSIONS: Open thoracoabdominal aortic repair in CTD patients can be performed safely with good short- and long-term outcomes, and durable visceral and renal branch-graft patency. However, ongoing surveillance is critical in detecting graft related complications, especially intercostal patch aneurysms, which may require intervention.
引用
- Natour AK, Mendes BC, Pochettino A, et al. Long-term outcomes of open thoracoabdominal aortic repair in connective tissue disease patients. J Vasc Surg. 2026. PMID: 42476200. doi:10.1016/j.jvs.2026.06.163
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。